- Home
- DOUG vs CBUS Comparison
DOUG vs CBUS Comparison
Compare DOUG & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOUG
- CBUS
- Stock Information
- Founded
- DOUG 1911
- CBUS 2010
- Country
- DOUG United States
- CBUS United States
- Employees
- DOUG N/A
- CBUS N/A
- Industry
- DOUG Building operators
- CBUS Agricultural Chemicals
- Sector
- DOUG Real Estate
- CBUS Industrials
- Exchange
- DOUG Nasdaq
- CBUS Nasdaq
- Market Cap
- DOUG 166.2M
- CBUS 160.8M
- IPO Year
- DOUG N/A
- CBUS 2017
- Fundamental
- Price
- DOUG $1.75
- CBUS $5.25
- Analyst Decision
- DOUG
- CBUS Strong Buy
- Analyst Count
- DOUG 0
- CBUS 3
- Target Price
- DOUG N/A
- CBUS $23.67
- AVG Volume (30 Days)
- DOUG 757.6K
- CBUS 129.6K
- Earning Date
- DOUG 11-05-2024
- CBUS 08-08-2024
- Dividend Yield
- DOUG N/A
- CBUS N/A
- EPS Growth
- DOUG N/A
- CBUS N/A
- EPS
- DOUG N/A
- CBUS N/A
- Revenue
- DOUG $951,674,000.00
- CBUS $2,961,000.00
- Revenue This Year
- DOUG $3.85
- CBUS $36.93
- Revenue Next Year
- DOUG $17.40
- CBUS $236.45
- P/E Ratio
- DOUG N/A
- CBUS N/A
- Revenue Growth
- DOUG N/A
- CBUS 816.72
- 52 Week Low
- DOUG $1.00
- CBUS $4.26
- 52 Week High
- DOUG $3.16
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- DOUG 48.18
- CBUS 33.11
- Support Level
- DOUG $1.42
- CBUS $4.26
- Resistance Level
- DOUG $1.91
- CBUS $7.49
- Average True Range (ATR)
- DOUG 0.17
- CBUS 0.67
- MACD
- DOUG -0.04
- CBUS -0.13
- Stochastic Oscillator
- DOUG 40.88
- CBUS 26.61
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.